Monoamine oxidase inhibitors in the control of migraine.
D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D008881:Migraine Disorders / Q000517:prevention & control*; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D012701:Serotonin / Q000097:blood
D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D012701:Serotonin